Table 1.

Characteristics of gout patients stratified by disease severity and logistic regression models

CovariatesMild*Moderate*Severe*Univariate analyses**Multivariate analyses
n=272n=130n=62OR (95% CI)$#$(OR (95% CI)$#$
Age in years (mean)70.871.971.81.01 (0.99–1.02)N/A
Female sex (%)12.918.522.61.67 (1.01–2.76)1.54 (0.85–2.80)
Education ≤9 years (%)24.827.646.61.46 (0.97–2.21)N/A
Diabetes (%)22.827.127.41.29 (0.84–1.98)N/A
Kidney disease (%)6.69.311.31.59 (0.81–3.12)N/A
BMI (mean)27.928.227.81.02 (0.97–1.06)N/A
Hyperlipidemia (%)29.444.246.82.00 (1.36–2.95)2.13 (1.39–3.28)
Duration of gout in years (mean)10.411.28.51.00 (0.98–1.01)N/A
Total number of attacks (%):
 119.56.412.1refref
 2–550.040.839.71.93 (1.01–3.67)1.51 (0.77–2.96)
 6–1014.820.813.82.98 (1.42–6.25)2.12 (0.97–4.62)
 >1015.632.034.55.00 (2.48–10.09)3.15 (1.49–6.65)
Attack during the last month (%)11.530.430.63.43 (2.10–5.61)1.81 (1.36–2.41)
ULT (%)46.350.850.00.85 (0.46–1.55)N/A
HAQ§ (mean)0.240.290.511.56 (1.09–2.24)1.20 (0.80–1.81)
Tophus (%)14.321.34.81.17 (0.69–1.98)N/A
  • *Self-reported disease severity. **ORs reflects yes vs no for dichotomous covariates, per year for age and duration and per unit for HAQ. $#$Moderate/severe vs mild, Urate-lowering therapy. §Health assessment questionnaire.